This study investigates pancreatic ductal adenocarcinoma (PDAC).
The focus is on evaluating a diagnostic prediction model using elastase-1, serological exams, and imaging like endoscopic ultrasonography to improve early diagnosis.
- Who can participate: Adults 18 years or older with pancreatic cancer, high-risk factors, or related conditions can participate. Healthy individuals without pancreatic disease are also eligible as controls.
- Study details: Participants will be involved in testing that includes enzyme tests, blood tests, and imaging. A placebo is not involved in this study.